Neuraltus Pharmaceuticals, Inc.
4 clinical trials · Sponsor
◉ Watch Neuraltus Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation (NCT02794857) | Neuraltus Pharmaceuticals, Inc. | 2016-08-29 |
| A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT01281631) | Neuraltus Pharmaceuticals, Inc. | 2011-02-01 |
| Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS) (NCT01091142) | Neuraltus Pharmaceuticals, Inc. | 2010-07-01 |
| Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy (NCT00957918) | Neuraltus Pharmaceuticals, Inc. | 2009-10-01 |
Track Neuraltus Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.